|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500111607 |
|
最近更新日期: Date of Last Refreshed on: |
2025-11-03 17:13:54 |
|
注册时间: Date of Registration: |
2025-11-03 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
3D打印定制人工椎体固定方式对椎体重建效果的影响——一项前瞻性、多中心、观察性队列研究 |
|
Public title: |
The Impact of 3D-Printed Artificial Vertebral Body Fixation Methods on Vertebral Reconstruction Outcomes: A Prospective, Multicenter, Observational Cohort Study |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
3D打印定制人工椎体固定方式对椎体重建效果的影响——一项前瞻性、多中心、观察性队列研究 |
|
Scientific title: |
The Impact of 3D-Printed Artificial Vertebral Body Fixation Methods on Vertebral Reconstruction Outcomes: A Prospective, Multicenter, Observational Cohort Study |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
杨庆诚 |
研究负责人: |
马昕 |
|
Applicant: |
Yang Qingcheng |
Study leader: |
Ma xin |
|
申请注册联系人电话: Applicant telephone: |
+86 189 3017 7328 |
研究负责人电话:
Study leader's |
+86 189 3017 7328 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
tjyqc@163.com |
研究负责人电子邮件: Study leader's E-mail: |
maxin@sjtu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
上海交通大学附属第六人民医院(上海市第六人民医院) |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
|
|
申请注册联系人通讯地址: |
中国上海市徐汇区宜山路600号 |
研究负责人通讯地址: |
中国上海市徐汇区宜山路600号 |
|
Applicant address: |
No. 600 Yishan Road, Xuhui District, Shanghai, China |
Study leader's address: |
No. 600 Yishan Road, Xuhui District, Shanghai, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
上海市第六人民医院 |
||
|
Applicant's institution: |
Shanghai JiaoTong university Affiliated Sixth People‘s Hospital |
||
|
研究负责人所在单位: |
上海市第六人民医院 |
||
|
Affiliation of the Leader: |
Shanghai JiaoTong university Affiliated Sixth People‘s Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2025-KY-217(K) |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海市第六人民医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Shanghai Sixth People‘s Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-06-20 00:00:00 | ||
|
伦理委员会联系人: |
庞路阳 |
||
|
Contact Name of the ethic committee: |
Luyang Pang |
||
|
伦理委员会联系地址: |
中国上海市徐汇区宜山路 600 号 |
||
|
Contact Address of the ethic committee: |
No. 600 Yishan Road, Xuhui District, Shanghai, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 21 6436 9181 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
上海市第六人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Shanghai JiaoTong university Affiliated Sixth People‘s Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国上海市徐汇区宜山路 600 号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 600 Yishan Road, Xuhui District, Shanghai, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
维度(西安)生物医疗科技有限公司 |
||||||||||||||||||||||
|
Source(s) of funding: |
Dimension (Xi'an) Biomedical Technology Co., Ltd. |
||||||||||||||||||||||
|
研究疾病: |
脊柱肿瘤、脊柱结核、创伤等疾患 |
||||||||||||||||||||||
|
Target disease: |
Spinal tumors, spinal tuberculosis, trauma, and other disorders |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
本研究的目的是评价在3D打印胸腰椎人工椎体重建术中采用不同固定方式对椎体重建效果的影响,为临床决策提供依据。 |
||||||||||||||||||||||
|
Objectives of Study: |
The purpose of this study is to evaluate the impact of different fixation methods on the effect of vertebral reconstruction in 3D-printed thoracolumbar artificial vertebral body reconstruction surgery, so as to provide a basis for clinical decision-making. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.患者年龄在18-80岁(包括18及80岁),性别不限; 2.患者因肿瘤、创伤、椎体结核等因素导致需要进行2节段及以上胸腰椎椎体切除重建的; 3.患者自愿参加并已签署知情同意书。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Patients aged 18 to 80 years inclusive, with no gender restrictions; 2. Patients requiring reconstruction involving resection of two or more segments of the thoracolumbar spine due to factors such as tumours, trauma, or vertebral tuberculosis; 3. Patients who voluntarily participate and have signed an informed consent form. |
||||||||||||||||||||||
|
排除标准: |
1.全身或局部存在活动性感染(结核除外),未得到有效控制的; 2.存在全身性疾病不能耐受麻醉或手术者,包括凝血功能障碍、严重心脏病、严重呼吸系统疾病等; 3.已经证实对金属材料过敏或不耐受者; 4.患有精神疾病,精神上无能力或者不能理解参与研究的要求,难以配合者; 5.妊娠试验呈阳性者; 6.入组前3个月内参加其他任何临床试验患者; 7.研究者判断不适合入选的其他情况。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Active systemic or localised infection (excluding tuberculosis) that is not effectively controlled; 2. Presence of systemic disease rendering the subject unable to tolerate anaesthesia or surgery, including coagulation disorders, severe cardiac disease, or severe respiratory disease; 3. Confirmed allergy or intolerance to metallic materials; 4. Psychiatric disorders rendering the subject mentally incapable or unable to comprehend study requirements, or demonstrating significant non-compliance; 5. Positive pregnancy test; 6. Participation in any other clinical trial within the three months preceding enrolment; 7. Other circumstances deemed ineligible by the investigator. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-03-01 00:00:00至 To 2028-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2025-11-13 00:00:00 至 To 2028-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |